Judgment Header
AstraZeneca AB (SE) v Sanofi-Aventis Singapore Pte Ltd [2012] SGHC 16
Loading…
[2012] SGHC 16
General Division of the High Court of Singapore19 Jan 2012Suit No 416 of 2011 (Summons 5001/2011/M)
Published judgment text with court metadata, source links, and stable paragraph anchors.
Cited in 2 later decisions. No negative treatment detected.
Citations and treatment detected automatically from later judgments and the authorities this decision relies on.
Later cases and laws citing this decision
“es Act instead of the Patents Act and, as such, s 82(1) of the Patents Act should not have been applicable at all. In this regard, Ms Leow cited AstraZeneca AB (SE) v Sanofi-Aventis Singapore Pte Ltd [2012] SGHC 16 (“Sanofi-Aventis”) at [30] for the proposition that an action brought pursuant to s 12A of the Medicines”
“nt infringement action would have required particulars of past infringing acts: see ss 66 and 67 of the PA and O 87A r 2(2) of the ROC; see also AstraZeneca AB (SE) v Sanofi-Aventis Singapore Pte Ltd [2012] SGHC 16 (“AstraZeneca”) at [20]–[23] and [30]. Instead, the Plaintiff relied on reg 24(1)(a)(i) of the TPR and, a”
Earlier cases and laws this decision relies on
No outgoing citations detected.
Auto-detected from judgment text; not a substitute for a citator check.
Judgment Header
AstraZeneca AB (SE) v Sanofi-Aventis Singapore Pte Ltd [2012] SGHC 16
Case Metadata
Case No: Suit No 416 of 2011 (Summons 5001/2011/M)
Case Metadata
Court: General Division of the High Court of Singapore
Case Metadata
Decision Date: 2012-01-19
Wrong text, a broken link, out-of-date content, or a removal request — tell us and we'll check it against the official source.